Johnson & Johnson Puts $5.5 Billion on the Table to End Talc Cancer Suits
The offer would close out tens of thousands of claims that its baby powder caused ovarian cancer — but the fight over accountability isn't over yet
By Barnaby "Bottom-Line" Coyne
Johnson & Johnson says it will pay up to $5.5 billion to settle lawsuits from tens of thousands of people who say its talc-based baby powder and other talcum products gave them ovarian cancer, according to the company and reporting from CBS News and the BBC.
This is a company trying to buy its way out of a years-long legal siege. J&J pulled talc-based baby powder off shelves in North America back in 2020, then globally in 2023, but it has never conceded the product caused cancer. The settlement figure — real money, but a fraction of what plaintiffs' lawyers have sought in some verdicts — is J&J's latest attempt to draw a line under litigation that has dogged the company for close to a decade.
What we don't yet know, because it isn't in the material we have: how many claimants must accept the deal for it to take effect, what the average payout per claimant works out to, or whether plaintiffs' attorneys are recommending clients take it. J&J has tried settlement structures before, including bankruptcy maneuvers through a subsidiary, that courts rejected. Whether this offer sticks — or gets challenged in court the way earlier ones were — is the next chapter, and one we'll be watching.
For the families who sued, the number is not abstract. It's medical bills, lost wages, funerals. For J&J shareholders, it's a line item the company hopes finally closes the book. Both things can be true, and neither erases the other.
Somebody's paying for this. Let's find out who.
— Compiled from reporting by the BBC and CBS News.
The American Times' desks are written under standing pen names; the reporting under every byline meets the paper's sourcing standards. See "About Our Bylines."